Literature DB >> 20501293

The narrow specificity pyroglutamate amino peptidase degrading TRH in rat brain is an ectoenzyme.

J L Charli1, C Cruz, M A Vargas, P Joseph-Bravo.   

Abstract

In order to determine the pathway of extracellular metabolism of the thyrotropin releasing hormone (pyroglu-his-proNH(2)) in brain, the topographical organization of pyroglutamate aminopeptidase II on the plasma membrane was investigated. Its activity was only slightly increased when intact brain synaptosomes were lysed by osmotic shock or detergent treatment. Trypsin treatment of intact synaptosomes destroyed 70-80% of enzyme activity without affecting lactate dehydrogenase. Pyroglutamate aminopeptidase II activity was present in primary cultures of foetal mice cortical cells. It was detected in intact cells, was not released by the cells and its activity was not increased by saponin pretreatment. Trypsin treatment of the cells reduced pyroglutamate aminopeptidase II by 70% but did not affect pyroglutamate aminopeptidase I and lactate dehydrogenase. These data support that brain pyroglutamate aminopeptidase II is an ectoenzyme. They suggest that this enzyme could be responsible for thyrotropin releasing hormone extracellular catabolism in brain.

Entities:  

Year:  1988        PMID: 20501293     DOI: 10.1016/0197-0186(88)90060-5

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

1.  The ups and downs of thyrotropin-releasing hormone.

Authors:  Kristen R Vella; Anthony N Hollenberg
Journal:  Endocrinology       Date:  2009-05       Impact factor: 4.736

2.  Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II.

Authors:  Julie A Kelly; Gaia A Scalabrino; Gillian R Slator; Aoife A Cullen; John F Gilmer; David G Lloyd; Geoffrey W Bennett; Karl Bauer; Keith F Tipton; Carvell H Williams
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

3.  Regulation of adenohypophyseal pyroglutamyl aminopeptidase II activity by thyrotropin-releasing hormone and phorbol esters.

Authors:  M A Vargas; M Cisneros; P Joseph-Bravo; J L Charli
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 4.  Multifactorial modulation of TRH metabolism.

Authors:  P Joseph-Bravo; R M Uribe; M A Vargas; L Pérez-Martínez; T Zoeller; J L Charli
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

5.  In vitro TRH release from hypothalamus slices varies during the diurnal cycle.

Authors:  L Covarrubias; J L Redondo; M A Vargas; R M Uribe; M Méndez; P Joseph-Bravo; J L Charli
Journal:  Neurochem Res       Date:  1994-07       Impact factor: 3.996

Review 6.  Advances in TRH signaling.

Authors:  Patricia Joseph-Bravo; Lorraine Jaimes-Hoy; Jean-Louis Charli
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

Review 7.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.